Saltar al contenido principal

Artificial Intelligence-Based Quantification to Assess the Automatic Psoriasis Area and Severity Index (APASI)

· 2 min de lectura
Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Peer-reviewed journal

The APASI, our innovative system for automated psoriasis severity assessment, is detailed in JEADV Clinical Practice. This study demonstrates our advancement in creating AI-powered solutions for precise dermatological evaluations.

Mac Carthy T, Dagnino D, Medela A, Fernández G, Aguilar A, Martorell A, Gómez-Tejerina P, Roustán-Gullón G. Artificial Intelligence-Based Quantification to Assess the Automatic Psoriasis Area and Severity Index. JEADV Clin Pract. 2025. https://doi.org/10.1002/jvc2.70143

The APASI represents a breakthrough in psoriasis assessment technology, as highlighted in recent scientific validation:

APASI provides a robust AI-driven framework for psoriasis severity assessment, delivering rapid, objective, and precise evaluations. Its integration into clinical and research workflows could enhance disease monitoring, improve treatment assessment and reduce evaluation costs.

Mac Carthy T, Dagnino D, Medela A, et al. Artificial Intelligence-Based Quantification to Assess the Automatic Psoriasis Area and Severity Index. JEADV Clin Pract. 2025. https://doi.org/10.1002/jvc2.70143